Anti-CD20 antibody-related pyoderma gangrenosum

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2016卷 / 1期
关键词：
D O I：
10.1007/s40278-024-62495-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [41] The design, construction and function of a new chimeric anti-CD20 antibody
    Wang, Yugang
    Feng, Jiannan
    Huang, Ying
    Gu, Xin
    Sun, Yingxun
    Li, Yan
    Shen, Beifen
    JOURNAL OF BIOTECHNOLOGY, 2007, 129 (04) : 726 - 731
  • [42] Ublituximab, a Novel, Glycoengineered Anti-CD20 Monoclonal Antibody (mAb), Demonstrates Enhanced Antibody-Dependent Cellular Cytotoxicity (ADCC) Relative to Other Anti-CD20 mAbs
    Huang, Deren
    Alvarez, Enrique
    Miskin, Hari
    Lee, Lily
    Foley, John
    NEUROLOGY, 2023, 100 (17)
  • [43] Immunotherapy with anti-CD20 compounds
    von Schilling, C
    SEMINARS IN CANCER BIOLOGY, 2003, 13 (03) : 211 - 222
  • [44] Anti-CD20 for rheumatoid arthritis
    Edwards, JC
    Leandro, MJ
    Cambridge, G
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 25 - 25
  • [45] Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders
    Faye, A
    Van Den Abeele, T
    Peuchmaur, M
    MAthieu-Boue, A
    Vilmer, E
    LANCET, 1998, 352 (9136): : 1285 - 1285
  • [46] Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma
    Giovanni Antonini
    Maria Cristina Cox
    Enrico Montefusco
    Antonella Ferrari
    Esmeralda Conte
    Stefania Morino
    Pamela Latino
    Guido Trasimeni
    Bruno Monarca
    Journal of Neuro-Oncology, 2007, 81 : 197 - 199
  • [47] Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin
    Ly, Sophia
    Nedosekin, Dmitry
    Wong, Henry K.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (02) : 247 - 273
  • [48] Oxidative modification of an anti-CD20 antibody imparts autophilic binding kinetics
    Gao, Fan
    Kindt, Thomas
    Lipinski, Christopher
    CANCER RESEARCH, 2009, 69
  • [49] Treatment of resistant pemphigus vulgaris with an anti-CD20 monoclonal antibody (Rituximab)
    Cooper, HL
    Healy, E
    Theaker, JM
    Friedmann, PS
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2003, 28 (04) : 366 - 368
  • [50] Treatment of benign orbital pseudolympholmas with the monoclonal anti-CD20 antibody rituiximab
    Witzig, Thomas E.
    Inwards, David J.
    Habermann, Thomas M.
    Dogan, Ahmet
    Kurtin, Paul J.
    Gross, John B., Jr.
    Ananthamurthy, Anuradha
    Ristow, Kay M.
    Garrity, James A.
    MAYO CLINIC PROCEEDINGS, 2007, 82 (06) : 692 - 699
12345